Bayer Aspirin Low Dose Chewable Tablets can help protect your heart by helping to prevent a second heart attack when taken as directed by your doctor. Aspirin is not appropriate for everyone, so be sure to talk to your doctor before you begin an aspirin regimen. Each low dose aspirin tablet contains 81 mg aspirin and can be taken to help reduce the chance of a second heart attack by 31%. With 81 mg of low dose aspirin per tablet, Bayer Aspirin Low Dose Chewable Tablets are made for adults to help prevent another heart attack or ischemic stroke. Conveniently chewable for those who have trouble swallowing, each 81mg aspirin tablet is also caffeine and sodium-free. Bayer Aspirin also provides relief of minor body aches and pains. When taking for pain, take 4 to 8 tablets every 4 hours with a full glass of water. Do not exceed 48 tablets in 24 hours. Use as directed.
- 81mg Aspirin can also be taken for temporary relief of minor body aches and pains
- Helps prevent a second heart attack by 31% and another ischemic stroke by 22%
- Made for adults who have difficulty swallowing pills
- These low dose aspirin chewable tablets are sodium and caffeine-free
- When taking for pain, take 4 to 8 tablets every 4 hours with a full glass of water. Do not exceed 48 tablets in 24 hours
- Bayer Aspirin has been a leading brand for second cardiovascular prevention
Shipping Note: Shipping to Alaska, Hawaii, PO Boxes, and APO addresses is not available for this item
Legal Disclaimer: Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.
Expiration Note: Amazon and Woot work hard to ensure that expired products are not shipped from Amazon fulfillment centers, but the nature of our business means that products with different expiration dates are shipped and thus we have no specific dates to disclose in advance. If you have concerns about the expiration dates on a product you have received, please reach out to Customer Service.
